GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 805 filers reported holding GLAXOSMITHKLINE PLC in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $517,000 | +30.9% | 11,882 | +30.9% | 0.07% | +43.8% |
| Q1 2022 | $395,000 | +6.5% | 9,076 | +7.8% | 0.05% | +9.1% |
| Q4 2021 | $371,000 | +9.1% | 8,420 | -5.3% | 0.04% | -6.4% |
| Q3 2021 | $340,000 | +13.3% | 8,892 | +17.9% | 0.05% | +6.8% |
| Q2 2021 | $300,000 | +28.8% | 7,541 | +15.3% | 0.04% | +15.8% |
| Q1 2021 | $233,000 | +33.9% | 6,541 | +38.7% | 0.04% | +18.8% |
| Q4 2020 | $174,000 | -35.3% | 4,715 | -34.0% | 0.03% | -45.8% |
| Q3 2020 | $269,000 | +31.9% | 7,144 | +42.9% | 0.06% | +31.1% |
| Q2 2020 | $204,000 | -83.7% | 4,998 | -84.9% | 0.04% | -78.5% |
| Q1 2020 | $1,251,000 | -11.3% | 33,082 | +8.6% | 0.21% | +22.9% |
| Q4 2019 | $1,410,000 | +18.9% | 30,467 | +8.3% | 0.17% | -6.6% |
| Q3 2019 | $1,186,000 | +8.3% | 28,141 | +1.7% | 0.18% | +5.2% |
| Q2 2019 | $1,095,000 | +20.3% | 27,666 | +24.6% | 0.17% | +8.1% |
| Q1 2019 | $910,000 | +40.2% | 22,197 | +28.5% | 0.16% | -7.5% |
| Q4 2018 | $649,000 | +247.1% | 17,272 | +246.8% | 0.17% | +226.4% |
| Q3 2018 | $187,000 | -22.1% | 4,980 | -21.8% | 0.05% | -36.9% |
| Q2 2018 | $240,000 | +51.9% | 6,371 | +45.9% | 0.08% | +47.4% |
| Q1 2018 | $158,000 | +122.5% | 4,368 | +87.2% | 0.06% | +103.6% |
| Q4 2017 | $71,000 | -58.5% | 2,333 | -48.7% | 0.03% | -60.6% |
| Q3 2017 | $171,000 | +5.6% | 4,546 | +4.6% | 0.07% | -1.4% |
| Q2 2017 | $162,000 | -4.7% | 4,345 | +3.5% | 0.07% | -4.0% |
| Q1 2017 | $170,000 | +169.8% | 4,197 | +128.2% | 0.08% | +134.4% |
| Q4 2016 | $63,000 | -48.4% | 1,839 | -39.6% | 0.03% | -60.0% |
| Q3 2016 | $122,000 | +9.9% | 3,044 | +11.7% | 0.08% | +5.3% |
| Q2 2016 | $111,000 | +12.1% | 2,725 | +6.4% | 0.08% | +18.8% |
| Q1 2016 | $99,000 | +106.2% | 2,562 | +97.2% | 0.06% | +93.9% |
| Q4 2015 | $48,000 | +29.7% | 1,299 | +27.5% | 0.03% | +26.9% |
| Q3 2015 | $37,000 | -9.8% | 1,019 | +0.4% | 0.03% | 0.0% |
| Q2 2015 | $41,000 | – | 1,015 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |